Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations.
D000164:Acremonium / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D001434:Bacteriophage Typing; D002353:Carrier State; D003428:Cross Infection / Q000382:microbiology*; D004196:Disease Outbreaks; D005260:Female; D006801:Humans; D008297:Male; D008404:Massachusetts; D008712:Methicillin / Q000494:pharmacology*; D008875:Middle Aged; D009254:Nafcillin / Q000494:pharmacology; D010403:Penicillin Resistance; D012141:Respiratory Tract Infections / Q000382:microbiology; D013183:Sputum / Q000382:microbiology; D013203:Staphylococcal Infections / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects / Q000254:growth & development / Q000302:isolation & purification*; D013204:Staphylococcus Phages; D014552:Urinary Tract Infections / Q000382:microbiology
D000900:Anti-Bacterial Agents; D009254:Nafcillin; D008712:Methicillin